Qiming Venture Partners

Qiming Venture Partners is a prominent venture capital firm established in 2006 and headquartered in Shanghai, with additional offices in Beijing, Suzhou, and Hong Kong. The firm specializes in investing in early to growth-stage companies across various sectors, including media and internet, information technology, consumer and retail, healthcare, and clean technology in China. Since its inception, Qiming has built a reputation as a leading investment firm in the region, managing multiple funds with over $1 billion in assets. The firm aims to support promising entrepreneurs and innovative businesses, contributing to the development of China's dynamic economic landscape.

Artavazd Arumov Ph.D

Principal

Ryan Baker

Chief Financial Officer

Sam Chen

Associate

Nan Chen

Principal

Phil DiGiacomo

VP

Anna French

Partner

Jinda Gao

Executive Director

William Hu

Managing Partner

Duane Kuang

Co-Founder & Managing Partner

Grace Lee

Partner

Nisa Leung

Managing Partner

Shuo Mao

vice_president

Mark McDade

Partner

Will Mcconnell

VP

Gary Rieschel

Co-Founder & Managing Partner

Amy Tang

Venture Partner

Shiyu Wang

Partner

Bonnie Wang

Principal

Jing Wu

Partner

Kuantai Yeh

Partner

Janet Yu Ph.D

Partner

Oscar Zhang

Principal

Alex Zhou

Partner

Past deals in Series A

Bioyond Tech

Series A in 2023
Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.

DeepWay

Series A in 2023
Deepway is a smart vehicle manufacturer that provides intelligent driving solutions for the truck freight market. The company provides heavy-duty trucks with low wind resistance bodies, intelligent driving, distributed drive system with modular design based on the same hydrogen and electricity platform, allowing the logistics industry to benefit from smart freight system.

Soda Health

Series A in 2022
Soda Health is a healthcare technology company focused on building solutions that eliminate health inequities and create a healthier America.

DeepWay

Series A in 2022
Deepway is a smart vehicle manufacturer that provides intelligent driving solutions for the truck freight market. The company provides heavy-duty trucks with low wind resistance bodies, intelligent driving, distributed drive system with modular design based on the same hydrogen and electricity platform, allowing the logistics industry to benefit from smart freight system.

Auron Therapeutics

Series A in 2022
Auron Therapeutics is to develop therapies to cure cancer by radically changing the paradigm of cancer therapeutics from cell killing, to transformation of malignant cells into normal cells. This transformation, called differentiation therapy, reactivates endogenous cellular programs to elicit tumor cell maturation and the transition from cancer to normal tissue. Its unique platforms allow for integration of large-omic datasets and miniaturized high throughput flow cytometry to rapidly identify and validate multiple targets and drugs in primary human patient samples.

Biotree

Series A in 2022
Shanghai Biotree biotech Co., Ltd. engages in the development of life science research technology application. The company application is used for sample testing, big data analysis, and technical product development in the field of life sciences, as well as to provides professional services. It serves universities, research institutes, hospitals, and enterprises. The company was founded in 2013 and is based in Shanghai, China.

AskGene Pharma

Series A in 2022
AskGene Pharma is a biotechnology firm. It is developing novel cytokine prodrugs to address critical unmet medical needs in oncology and autoimmune disease. It is unlocking the full therapeutic potential of cytokine molecules with their innovative smart kine prodrug platform. It overcomes a number of significant challenges, providing a clear pathway to a range of next-generation cytokine therapies. They provide safer and better medicines for saving patients’ lives. They are equipped with the most advanced R&D facilities.

Houmo.AI

Series A in 2022
Houmo.AI is a semiconductor company that develops an integrated circuit storage technology for AI computing. The company aims to use disruptive technologies to create AI chips with a "ten-fold effect", to meet the huge computing power demand in the era of true artificial intelligence, and to use unlimited computing power to change the world. Houmo.AI was founded by Dr. Wu Qiang in 2020.

GluBio Therapeutics

Series A in 2022
GluBio Pharmaceutical focuses on molecular glue-targeted protein degradation and provides a multi-dimensional protein degradation screening platform, an innovative target validation platform, a molecular glue rational design platform, and a proprietary library of highly active molecules.

Wowjoy Technology

Series A in 2022
Wowjoy Technology develops a platform to provide data-driven medical services. The firm is headquartered in Hangzhou, China.

SilaGene, Inc.

Series A in 2022
Silagene is a biotech company developing technology designed to facilitate the creation of U1 adaptors with therapeutic potential. The company's technology overcomes the limitations of gene silencing technologies, enabling doctors to to treat patients with various types of cancers. It was founded in 2008 and is based in Hillsborough, New Jersey, United States.

MKSEMI

Series A in 2022
Provider of high precision location technology IC and solutions. The company focuses on developing high performance, low-power, and highly integrated IC and provides solutions in smartphones, wearables, digital health, smart home and general IoT applications.

Superhexa

Series A in 2021
Superhexa is a cutting-edge hardware firm that specializes in personal consumer electronics. Superhexa was founded at October 15, 2020 by Xia Yongfeng and is located in Beijing.

Gemsouls

Series A in 2021
Gemsouls is an AI technology that powers virtual characters and their interactions with the real world. Headquarterd in Shanghai.

Xinchuangyuan Semiconductor

Series A in 2021
Xinchuangyuan Semiconductor is a manufacturing company of electronic equipment. Xinchuangyuan Semiconductor was founded in 2021 and was headquartered in Wuhan, China.

Allorion Therapeutics

Series A in 2021
Allorion Therapeutics is a small molecule therapeutic development company that focuses on cancer and autoimmune illnesses. Allorion operates two locations in Natick, Massachusetts, and Guangzhou, China.

Supermag

Series A in 2021
Suzhou Supermag Intelligent Technology Co., Ltd. (hereinafter referred to as Suci Technology) is committed to the research and development, production and sales of maglev high-speed motors. With the design authorization of magnetic levitation compressors, magnetic levitation blowers, magnetic levitation pumps, etc., it provides core components such as magnetic levitation motors, magnetic levitation bearings, magnetic levitation controllers, and displacement sensors.

Cubenergy Technology

Series A in 2021
Shenzhen Cubenergy Technology Co., Ltd. is an energy technology company that specializes in offering comprehensive energy data operation services and integrating distributed energy storage systems. Founded in 2015 and headquartered in Shenzhen, China, the company focuses on enhancing energy management and efficiency through innovative technological solutions. Its services cater to diverse user needs, aiming to optimize energy utilization and support sustainable energy practices.

Wowjoy Technology

Series A in 2021
Wowjoy Technology develops a platform to provide data-driven medical services. The firm is headquartered in Hangzhou, China.

V Light

Series A in 2021
V Light is an interest social app.

Sanegene Bio

Series A in 2021
Sanegene Bio is currently operating in stealth mode.

BUD

Series A in 2021
Founded in 2019 by former Snap engineers, Risa Feng and Shawn Lin, Singapore-headquartered BUD is a leading global metaverse UGC platform encouraging users to create and share 3D interactive experiences with its easy-to-use creation tools. Since its global launch in November 2021, BUD skyrocketed to the list of top 10 social apps in more than 38 countries around the world including North America, Southeast Asia and South America. Millions of 3D content has been created and traded on the platform. BUD has become a digital social hub where millions of people come to create, play and hangout.

PlusLife Biotech

Series A in 2021
PlusLife Biotech is devoted to developing revolutionary molecular diagnostic tools and gene treatment programs employing a new generation of gene technology. Founded in 2017 and is based in Guangzhou, China.

InfStones

Series A in 2021
Infinity Stones is a Silicon Valley-based company that provides cloud management services and security solutions for blockchains. They are blockchain infrastructure architects with proven track records in the industry. Their team is composed of tech leads, management experts, and financial professionals from tech giants like Google, Oracle, and Intel. Infinity Stones is currently hosting nodes for high net worth individuals, institutional investors, foundations, and universities and research institutions. They make sure every investment with us is secure, and investors can expect returns with consistency. It was founded in 2018 and is headquartered in Palo Alto, California.

Allorion Therapeutics

Series A in 2021
Allorion Therapeutics is a small molecule therapeutic development company that focuses on cancer and autoimmune illnesses. Allorion operates two locations in Natick, Massachusetts, and Guangzhou, China.
Hochuen Medical was founded in 2015 by Dr. Robin Liu, an entrepreneur in IVD medical and microfluidics fields, and Eric Zeng, an expert in the electronics OEM industry. The founding management team has an average of more than 20 years of management experience in manufacturing of microfluidic devices, medical disposables, and consumer electronic products. Dr. Robin Liu, co-founder and president of Hochuen Medical, has more than 20 years of experience in the IVD and microfluidic industry, with experience at Motorola, CombiMatrix, GenMark, Beckman Coulter/Danaher, etc. Dr. Liu brings both experience in R&D and production management in the fields of molecular diagnosis, immunoassays, hematology, urinalysis, etc

MKSEMI

Series A in 2021
Provider of high precision location technology IC and solutions. The company focuses on developing high performance, low-power, and highly integrated IC and provides solutions in smartphones, wearables, digital health, smart home and general IoT applications.

Render

Series A in 2021
Render is a Chinese manufacturer of high-tech medical products and solutions. Render is a Shenzhen-based company that was founded in 2010.

MeetFuture China

Series A in 2021
MeetFuture China is a technology-driven company that supplies automated transmission systems for the pan-semiconductor industry. It provides automation solutions for leading companies in the semiconductor field since 2016 and provided a highly advantageous overall for industrial upgrading and development with independent and controllable core technologies.

Gaugene

Series A in 2021
Gaugene provides hematology testing instruments, reagents, and services for IVD users. Gaugene is a high-tech enterprise co-sponsored by core technology management backbones of well-known domestic IVD companies with rich management experience who master the industry’s top technologies.

Xizi Education

Series A in 2021
Xizhi Education (Beijing Xizi Education Technology Co., Ltd.) is a leading enterprise in artificial intelligence empowerment education. The headquarters is located in Zhizhi Street, Zhongguancun, which is known as the “China Silicon Valley”. As one of the key incubators of Tsinghua University, from the aspects of policy, capital and talents, it has been strongly supported by Tsinghua's three innovation and entrepreneurship platforms iCenter, Chuang+ and xlab, and won the honor of Zhongguancun High-tech Enterprise.

ZSHK Laboratories

Series A in 2021
ZSHK Lab is a company located in Wan Chai, Hong Kong Island, Hong Kong.

Sincere Edu

Series A in 2021
Sincere Edu is an online financial professional education brand. With CPA exam training as its entry point, it is committed to building a learning and growth platform that can accompany professional financial professionals throughout their careers. Sear Education hopes to truly meet the various needs of students by reconstructing the models and products of the financial professional education market; through the wisdom sharing and the cultivation of the teacher training system

Medilink-Global

Series A in 2021
Medilink-Global provides third-party administration solutions to health insurance and corporate organizations.

Medilink Therapeutics

Series A in 2021
MediLink Therapeutics has established its R&D center in Suzhou, China. The company focuses on developing next generation drug conjugates, and aims to serve the vast unmet medical needs in China, and create global value through conducting multicenter clinical trials and cross-border collaborations.

Casela

Series A in 2021
Casela is a chip and semiconductor company

Wholee

Series A in 2021
Wholee is a member-only zero-markup store.

Cornerstone Robotics

Series A in 2021
Cornerstone Robotics operates to improve the accessibility of high-end medical services in China.

LaNova Medicines

Series A in 2020
LaNova Medicines is a clinical-stage innovative drug research and development company. The company focuses on the unmet therapeutic needs in the field of tumor immunity and tumor microenvironment and focuses on the research and development of "world's first" and "best-in-class" potential bio-innovative drugs.

Cool Academy

Series A in 2020
Cool College is a Beijing-based software-as-a-service(SaaS) developer for employee training services.

Korro Bio

Series A in 2020
Korro Bio Inc. specializes in the development of nucleic acid-based therapeutics aimed at targeting specific sequences in genetic code, with a focus on treating rare diseases. Founded in 2018 and located in Cambridge, Massachusetts, the company utilizes a proprietary platform that enables efficient and selective RNA editing by leveraging natural processes found in multi-cellular organisms. This innovative approach allows Korro Bio to edit messenger RNA and recode specific codons, facilitating targeted modifications in protein structure and function across various tissues.

Zion Pharma

Series A in 2020
Zion is a leading drug discovery platform that develops "me-better" drugs that address true unmet needs.

HashQuark

Series A in 2020
HashQuark is a blockchain infrastructure services provider specializing in staking solutions for Proof of Stake (PoS) and Delegated Proof of Stake (DPoS) ecosystems. Founded in 2018 and based in Grand Cayman, the company offers a range of services, including staking for institutions, individuals, and market professionals, as well as advanced staking cloud solutions that facilitate efficient node operations. HashQuark has established a global server deployment supporting all major PoS blockchains, ensuring a secure and stable platform for token holders. Through its Staking Cloud, the company enables users to store their tokens and earn staking rewards, making it an attractive option for both individual and institutional investors seeking reliable investment opportunities in the blockchain space.

Elevation Oncology

Series A in 2020
Elevation Oncology, Inc. is a biotechnology company dedicated to creating precision medicines for patients with genomically defined cancers. Founded in 2019 and headquartered in New York, the company focuses on developing targeted therapies that inhibit specific genetic alterations associated with cancer progression. Its lead candidate, seribantumab, is designed to address tumor growth driven by NRG1 fusions and is currently undergoing clinical evaluation in the Phase 2 CRESTONE study, which includes patients with various tumor types exhibiting this genomic alteration. Through its innovative approach, Elevation Oncology aims to enhance treatment options for individuals with solid tumors linked to specific genetic drivers.

Biren Technology

Series A in 2020
Shanghai Biren Intelligent Technology Co., Ltd. specializes in the design and manufacture of intelligent chips, focusing on advanced computing solutions. The company operates in both software and hardware sectors, bringing together top industry talents, including technical experts and elite engineers, to develop innovative products. Its hardware division is dedicated to creating versatile computing solutions, while the software department enhances these offerings with specialized applications. Additionally, the company maintains a research institute that investigates key technologies related to intelligent computing systems, emphasizing the development of new architectures and advanced compilation techniques. Through these efforts, Biren Technology aims to establish itself as a leading player in the high-tech sector.

Origincell

Series A in 2020
OriginCell is a biomedical equipment enterprise that develops tumor immuno-therapy solutions. It develops tumor therapies and cellular drugs through the use of the 10-phage display library, humanized antibody technology platform, and antibody discovery platform that enable their medical facilities to apply in cancer treatments. OriginCell was founded in 2014 and is headquartered in Shanghai, China.

Kingsware

Series A in 2020
Kingsware specializes in developing a robotic process automation system. It is committed to building an enterprise-level safe robot management platform. Its product follows the design concept of safe, easy-to-use, powerful, stable, and efficient, and the system can be deployed and controlled in a large-scale, highly integrated enterprise complex environment.

Alamar Biosciences

Series A in 2020
Alamar Biosciences develops technologies for the detection and treatment of cancer and other diseases at the earliest possible time. The company was founded in 2018 and is headquartered in Hayward, California.

Chuhang Tech

Series A in 2020
Nanjing Chuhang Technology Co., Ltd. specializes in the development and production of millimeter-wave radar technology for advanced driver assistance systems (ADAS) and autonomous driving. The company offers a range of products, including 77 GHz angle radars and forward midrange radars, which are utilized in applications such as blind zone detection, automatic parking, emergency braking, adaptive cruise control, forward crossing warning, heartbeat breath detection, gesture recognition, and smart agriculture. Founded in 2018 and headquartered in Nanjing, China, Chuhang Tech has expanded its presence with subsidiaries in several Chinese cities, as well as in Stuttgart, Germany.

CureGenetics

Series A in 2020
CureGenetics is a healthcare company focused on the research and development of gene editing technologies and molecular diagnostics. It specializes in creating innovative medicines aimed at providing advanced treatments for cancers and genetic diseases. By developing a gene editing solution and a delivery platform, CureGenetics aims to enhance therapeutic options and improve patient outcomes in the field of genetic medicine.

Wuli Planet

Series A in 2020
Health Game Advice: Resist bad games, refuse pirated games, pay attention to self-protection, beware of being deceived, moderate games to benefit the brain, indulge in game injuries, arrange time properly and enjoy a healthy life.

Structure Therapeutics

Series A in 2020
ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.

Singular Medical

Series A in 2020
Singular Medical is a technology company specializing in R&D and industrialization of cardiac rhythm management (CRM) products. The company builds a complete technical platform and is a supplier of full line of CRM products, which provides a complete range of solutions, from detection to follow-up for large amounts of cardiac patients.

Berry Oncology

Series A in 2020
Berry Oncology develops medical technology intended to improve cancer prevention and tumor diagnosis. It offers genetic diagnosis solutions from early diagnosis to mid-late monitoring that can solve clinical problems in the direction of several malignant tumors, providing patients with a higher quality of life and reduced risk of cancer. The company's mission is early diagnosis and early treatment of all tumors, all patients receive precise treatment. Along with its vision to become a global icon in the field of early screening and early diagnosis of tumors and a leader in China's tumor gene testing market.

NVX Clouds Tech

Series A in 2020
NVX Clouds Tech is an artificial intelligence security computing company focused on data privacy protection. It utilizes unique privacy computing technology to fully protect local and cloud data privacy and security through the Cing Weixin privacy cloud computing platform and all-in-one product line. It also provides solutions for the protection of big data security and commercial secrets in finance. The company aims to build a privacy computing platform for big data, separate the ownership, management, and use rights of the data, fully realize the flow of data, and promote the fourth industrial revolution.

Fingo

Series A in 2020
Fingo is an online shopping platform for customers to buy products and share products with their friends. The platform incorporates social business models in Malaysia to connect and create customers. Fingo leverages on major social platforms where every member who signs up will be treated as a VIP and gain access to a wide selection of quality goods and suppliers from Tmall and Taobao, besides opening up new entrepreneurial opportunities via a members-reward system, allowing people get goods at a cheaper price but also earn through membership.

InfStones

Series A in 2020
Infinity Stones is a Silicon Valley-based company that provides cloud management services and security solutions for blockchains. They are blockchain infrastructure architects with proven track records in the industry. Their team is composed of tech leads, management experts, and financial professionals from tech giants like Google, Oracle, and Intel. Infinity Stones is currently hosting nodes for high net worth individuals, institutional investors, foundations, and universities and research institutions. They make sure every investment with us is secure, and investors can expect returns with consistency. It was founded in 2018 and is headquartered in Palo Alto, California.

Jasper Therapeutics

Series A in 2020
Jasper Therapeutics, Inc. is a biotechnology company based in Menlo Park, California, that specializes in developing therapeutic agents for hematopoietic stem cell transplants and gene therapies. Founded in 2018, the company is focused on creating safer and more effective conditioning agents to enhance the efficacy of stem cell transplants and gene therapies. Its lead product, JSP191, is a humanized monoclonal antibody currently in clinical development, designed to act as a conditioning agent by clearing hematopoietic stem cells from bone marrow. JSP191 targets the CD117 receptor, which is expressed on hematopoietic stem and progenitor cells, thereby facilitating safer transplant procedures and potentially broadening the application of curative therapies.
Clinflash is a leading provider of cloud-based solution and relevant professional service in filed of clinical development in China. Clinflash aims to help pharmaceutical companies improve R&D effectiveness and efficiency through providing first class IT solution and professional service.

SunnyDental

Series A in 2020
Sunny Dental offers orthodontics services. It offers diagnosis and treatment in the areas of dental implants, children’s dentistry, dental restorations, periodontal disease, dental pulp, oral and maxillofacial surgery, and invasive extraction. The company was founded in 2007 and is based in Beijing, China.

Jasper Therapeutics

Series A in 2019
Jasper Therapeutics, Inc. is a biotechnology company based in Menlo Park, California, that specializes in developing therapeutic agents for hematopoietic stem cell transplants and gene therapies. Founded in 2018, the company is focused on creating safer and more effective conditioning agents to enhance the efficacy of stem cell transplants and gene therapies. Its lead product, JSP191, is a humanized monoclonal antibody currently in clinical development, designed to act as a conditioning agent by clearing hematopoietic stem cells from bone marrow. JSP191 targets the CD117 receptor, which is expressed on hematopoietic stem and progenitor cells, thereby facilitating safer transplant procedures and potentially broadening the application of curative therapies.

Origincell

Series A in 2019
OriginCell is a biomedical equipment enterprise that develops tumor immuno-therapy solutions. It develops tumor therapies and cellular drugs through the use of the 10-phage display library, humanized antibody technology platform, and antibody discovery platform that enable their medical facilities to apply in cancer treatments. OriginCell was founded in 2014 and is headquartered in Shanghai, China.

Woof

Series A in 2019
Woof is a street fashion community and e-commerce platform for young generations.
Clinflash is a leading provider of cloud-based solution and relevant professional service in filed of clinical development in China. Clinflash aims to help pharmaceutical companies improve R&D effectiveness and efficiency through providing first class IT solution and professional service.

Yuanxin Huibao

Series A in 2019
Yuanxin Huibao is a health insurance technology service provider. It provides insurance for health care in major areas such as major diseases and chronic diseases. It provides users with more reliable medical and medical services and is more insurance. The company offers solutions such as “product actuarial pricing, risk control, user acquisition and viscosity”.

Icosavax

Series A in 2019
Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs and reduce healthcare costs. tHEY were founded on breakthrough computationally-designed virus-like particle technology, exclusively licensed for a variety of infectious disease indications from the Institute for Protein Design at the University of Washington.

Casela

Series A in 2019
Casela is a chip and semiconductor company

Platelet BioGenesis

Series A in 2019
Platelet BioGenesis is a biotechnology company focused on producing donor-independent human platelets from pluripotent stem cells for clinical use. Founded in 2014 and based in Cambridge, Massachusetts, the company has developed a microfluidic bioreactor that enables the generation of functional platelets at commercial scale from human stem cell cultures. Platelet BioGenesis distributes these bioreactor-produced platelets to hospitals and blood banks, aiming to provide a reliable source of platelets for patients worldwide. By specializing in the fields of platelets and drug discovery, the company is addressing critical needs in the medical community related to blood supply and treatment options.

Yuanxin Huibao

Series A in 2019
Yuanxin Huibao is a health insurance technology service provider. It provides insurance for health care in major areas such as major diseases and chronic diseases. It provides users with more reliable medical and medical services and is more insurance. The company offers solutions such as “product actuarial pricing, risk control, user acquisition and viscosity”.

Pulsar Technology

Series A in 2019
Pulsar is a basic software technology service provider, mainly engaged in technology development, technology promotion, technology transfer, technical consulting, and technical services.

ZD Medical

Series A in 2019
ZD Medical is a medical device company manufacturing optical coherence tomography angiography devices.

Nice Tuan

Series A in 2019
Nice Tuan is an e-commerce platform that specializes in providing daily groceries and a variety of household products. The company collaborates with local residential communities to source items from nearby warehouses and producers, ensuring a wide selection of fresh produce and essential goods for residents. By focusing on creating a convenient and efficient community e-commerce ecosystem, Nice Tuan aims to enhance the shopping experience for local consumers while supporting local suppliers.

Chuhang Tech

Series A in 2019
Nanjing Chuhang Technology Co., Ltd. specializes in the development and production of millimeter-wave radar technology for advanced driver assistance systems (ADAS) and autonomous driving. The company offers a range of products, including 77 GHz angle radars and forward midrange radars, which are utilized in applications such as blind zone detection, automatic parking, emergency braking, adaptive cruise control, forward crossing warning, heartbeat breath detection, gesture recognition, and smart agriculture. Founded in 2018 and headquartered in Nanjing, China, Chuhang Tech has expanded its presence with subsidiaries in several Chinese cities, as well as in Stuttgart, Germany.

Mech-Mind

Series A in 2019
Mech-Mind Robotics Technologies Ltd. designs, develops, and sells hardware and software solutions for logistics industry. The company manufactures smart cameras, such as Mech-Eye Smart Camera, Mech-Eye Broad Smart Camera, and Mech-Eye Pro S Smart Camera for object recognition, depalletizing, assembly, sorting, and locating. Mech-Mind Robotics Technologies Ltd. also develops software solution that allows robotic camera to recognize objects in different shapes and different sizes. In addition, the company also manufactures logistic parcels picking solution for logistic customers. Mech-Mind Robotics Technologies Ltd. was founded in 2016 and is based in Beijing, China with additional office in Munich, Germany and sale office in Shanghai, China.

Talaris Therapeutics

Series A in 2019
Talaris Therapeutics is a operator of a biotechnology company engaged in the development of innovative cellular therapies. The company's proprietary allogeneic cell therapy product has shown to induce tolerance in recipients of solid organ transplants from unmatched and unrelated donors, enabling living donor kidney transplant recipients to wean completely off immunosuppression one year after transplant.

Structure Therapeutics

Series A in 2019
ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.

Bomming Vision

Series A in 2019
Zhuhai Bomming Vision Technology is a high-tech company located in Chinese romantic city--Zhuhai. The company is committed to the development and application of machine vision technology. The core technology and management team members have more than 15 years of experience in image acquisition, recognition, algorithm, and machine vision inspection.

52toys

Series A in 2019
Animation and Intellectual Property Operator based in Beijing.

Gohoo

Series A in 2019
Gohoo is a boutique e-commerce platform that directly links high-quality goods and suppliers channels by integrating the factory supply chain, thereby reducing the brand premium. The current categories focus on beauty, home, food and so on.

Zion Pharma

Series A in 2019
Zion is a leading drug discovery platform that develops "me-better" drugs that address true unmet needs.

LuPu Investment

Series A in 2019
Lupu Investment Management Co., Ltd. is a privately owned investment manager. The firm also manages private equity fund of funds. It was founded in 2013 and is headquartered in Shanghai, China.

V Light

Series A in 2019
V Light is an interest social app.

Try Try

Series A in 2018
Try Try is a clothing brand and concept store.

Chaodian Culture

Series A in 2018
Chaodian Culture

Woof

Series A in 2018
Woof is a street fashion community and e-commerce platform for young generations.

Reelsky Data Systems

Series A in 2018
Beijing Reelsky Data Technology Co., Ltd. offers big data analytics, modeling and data application services. The firm is headquartered in Beijing, China.

WeRide

Series A in 2018
Guangzhou WeRide Technology Co., Ltd. develops autonomous driving technology for level 4 AD cars. The company also develops own AD hardware solution to fit on cars for surround sensor coverage and full spectrum. The company was founded in 2017 and is headquartered in Guangzhou, China.
NASN Automotive Electronics is committed to providing advanced and complete chassis electronic control products, ADAS and autonomous driving related core technologies for the Chinese automotive market. The main products include NBooster intelligent brake system, brushless electric steering EPS controller and wire control system. It is a scientific and technological innovation enterprise integrating R&D, production and sales.

Cubenergy Technology

Series A in 2018
Shenzhen Cubenergy Technology Co., Ltd. is an energy technology company that specializes in offering comprehensive energy data operation services and integrating distributed energy storage systems. Founded in 2015 and headquartered in Shenzhen, China, the company focuses on enhancing energy management and efficiency through innovative technological solutions. Its services cater to diverse user needs, aiming to optimize energy utilization and support sustainable energy practices.

TUNGEE

Series A in 2018
Guangzhou Tungee Technology Co.,Ltd., a software as a service (SaaS) company, develops intelligent sales cloud platform. It provides leads mining, business opportunity engagement, customer relationship management, and order analysis for enterprises. The company offers Tungee intelligent sales cloud platform , outbound leads, inbound leads, engage, cloud-based call center, intelligent call, and CRM products. It also offers Tungee galaxy, prophecy, and discernment solutions. Guangzhou Tungee Technology Co.,Ltd. was founded in 2016 and is based in Panyu, China.

Cool Math

Series A in 2018
Founded in January 2018, Beijing Tianfutong Education Technology Co., Ltd. is an excellent technical and operational talent from education companies such as New Oriental, Good Future, and Gaosi, as well as outstanding technical talents from Internet companies such as Baidu, Sohu, and Meituan. Founded a new online education brand. Based on original quality education content and technology-driven, we provide high-quality online mathematics thinking learning content and services for children aged 3-12.